右美托咪定与全凭静脉麻醉预防小儿苏醒期谵妄:网状Meta分析
该系统评价与网状Meta分析纳入66项随机对照试验共5257例患儿,比较右美托咪定复合七氟烷与全凭静脉麻醉对小儿苏醒期谵妄的影响。结果显示两者谵妄发生率无统计学差异(RR 0.88,95%CI 0.61–1.20),但右美托咪定组术后恶心呕吐发生率更高(RR 2.3,95%CI 1.1–5.6),证据质量低,推荐为条件性。
要点
- 右美托咪定复合七氟烷与全凭静脉麻醉的苏醒期谵妄发生率无统计学差异。
- 右美托咪定复合七氟烷组的术后恶心呕吐发生率高于全凭静脉麻醉组。
- 证据质量低,选择方案需结合患儿谵妄与术后恶心呕吐风险因素个体化判断。
核心结论
- 右美托咪定复合七氟烷与全凭静脉麻醉对小儿苏醒期谵妄的预防效果无统计学差异,但右美托咪定组术后恶心呕吐发生率更高。
研究设计与样本
- 系统评价与网状Meta分析,纳入66项随机对照试验,共5257例患儿,检索12个数据库至2020年12月。
主要发现
- 右美托咪定复合七氟烷、全凭静脉麻醉和单纯七氟烷组的苏醒期谵妄粗中位发生率分别为12.8%、9.1%和40%。
- 与全凭静脉麻醉相比,右美托咪定复合七氟烷降低苏醒期谵妄发生率但无统计学差异(RR 0.88,95%CI 0.61–1.20,低质量证据)。
- 与全凭静脉麻醉相比,右美托咪定复合七氟烷的术后恶心呕吐发生率更高(RR 2.3,95%CI 1.1–5.6,低质量证据)。
关键数值与推荐
- 推荐根据患儿发生苏醒期谵妄和术后恶心呕吐等临床显著结局的风险因素进行临床判断,以选择全凭静脉麻醉或右美托咪定复合七氟烷(条件性推荐,证据质量低)。
临床怎么用
- 临床选择全凭静脉麻醉或右美托咪定复合七氟烷时,应权衡患儿苏醒期谵妄与术后恶心呕吐的风险。
局限性
- 证据质量低,结论受限,推荐为条件性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emergence delirium is a common complication in paediatric anaesthesia associated with significant morbidity. Total intravenous anaesthesia (TIVA) and intra-operative dexmedetomidine as an adjuvant to sevoflurane anaesthesia can both reduce the incidence of emergence delirium compared with sevoflurane alone, but no studies have directly compared their relative efficacy. OBJECTIVE: The study objective was to compare the effects of TIVA and dexmedetomidine on the incidence of paediatric emergence delirium. STUDY DESIGN: The current study is a systematic review and network meta-analysis (NMA) of randomised controlled trials. DATA SOURCES: We conducted a systematic search of 12 databases including Medline (Ovid) and Web of Science (Clarivate Analytics) from their respective inception to December 2020. ELIGIBILITY: Inclusion criteria were randomised controlled trials of paediatric patients undergoing general anaesthesia using sevoflurane, sevoflurane with dexmedetomidine or TIVA. Data were extracted by two reviewers according to Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines and analysed using NMA methodology. Risk ratios and 95% credible intervals (CrI) were calculated for all outcomes [emergence delirium, postoperative nausea and vomiting (PONV), and time to emergence and extubation]. The protocol was registered with PROSPERO (CRD42018091237). RESULTS: The systematic review returned 66 eligible studies comprising 5257 patients with crude median emergence delirium incidences of 12.8, 9.1 and 40% in the dexmedetomidine with sevoflurane, TIVA and sevoflurane alone groups, respectively. NMA indicated that compared with TIVA, sevoflurane with adjuvant dexmedetomidine decreased the incidence of emergence delirium without statistical difference (risk ratio 0.88, 95% CrI 0.61 to 1.20, low quality of evidence), but resulted in a higher incidence of PONV (risk ratio: 2.3, 95% CrI 1.1 to 5.6, low quality of evidence). CONCLUSION: Clinical judgement, considering the patient's risk factors for the development of clinically significant outcomes such as emergence delirium and PONV, should be used when choosing between TIVA and sevoflurane with adjuvant dexmedetomidine. These findings are limited by the low quality of evidence (conditional recommendation).
引用
- Petre MA, Levin DN, Englesakis M, et al. Dexmedetomidine vs. total intravenous anaesthesia in paediatric emergence delirium: A network meta-analysis. Eur J Anaesthesiol. 2021. PMID: 33720063. doi:10.1097/EJA.0000000000001490
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。